Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The Goto-Kakizaki (GK) rat, an animal model of type 2 diabetes, exhibits mild hyperglycemia with a reduction of beta-cell mass. The mechanism for islet structural changes in this model and whether the changes are affected by metabolic control are not known. In the present study, we examined the process of islet changes in male GK rats aged 6, 8, 12, 24, and 36 weeks. Treatment effects with an alpha-glucosidase inhibitor (Voglibose; Takeda, Osaka, Japan) for 24 weeks (12 to 36 weeks of age) were also evaluated. The beta-cell mass increased until 8 weeks of age in both GK and control rats, but the increase was significantly (P < .01) smaller in GK rats versus at 8 weeks of age. Thereafter, the beta-cell mass decreased in GK rats, whereas it remained constant in controls. Voglibose treatment significantly (P < .01) inhibited the reduction of beta-cell mass in GK rats. Proliferative activity of beta cells as measured by bromodeoxyuridine (BrdU) uptake was significantly (P < .05) lower in GK rats versus control rats at 6 and 8 weeks, but the difference disappeared after 12 weeks of age, regardless of Voglibose treatment. The present study thus demonstrates a progressive loss of beta cells in GK rats that was mitigated by Voglibose treatment. We consider that the beta-cell loss in GK rats was due to an early impairment in proliferative activity and reduced survival. Voglibose did not appear to stimulate beta-cell proliferation, but exerted its effect via a reduction of hyperglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to pioglitazone, α-glucosidase inhibitors attenuate reductions in β-cell mass, which may delay the onset of diabetes.374, 375, 376”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [375]
Citations
Cites
Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
Ihara, Y., Toyokuni, S., Uchida, K., Odaka, H., Tanaka, T., Ikeda, H., Hiai, H., Seino, Y., & Yamada, Y. (1999) · Diabetes · doi:10.2337/diabetes.48.4.927 · Cited by 506
Self-citationUnger, R. H., & Grundy, S. (1985) · Diabetologia · doi:10.1007/bf00273856 · Cited by 452
Donath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405
Cellular composition of the human diabetic pancreas
Rahier, J., Goebbels, R. M., & Henquin, J. C. (1983) · Diabetologia · doi:10.1007/bf00251826 · Cited by 395
Matsuoka, T., Kajimoto, Y., Watada, H., Kaneto, H., Kishimoto, M., Umayahara, Y., Fujitani, Y., Kamada, T., Kawamori, R., & Yamasaki, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119126 · Cited by 359
Shafrir, E. (1984) · Medical Entomology and Zoology · Cited by 355
Quantitation of Endocrine Cell Content in the Pancreas of Nondiabetic and Diabetic Humans
Stefan, Y., Orci, L., Malaisse-Lagae, F., Perrelet, A., Patel, Y., & Unger, R. H. (1982) · Diabetes · doi:10.2337/diab.31.8.694 · Cited by 272
Spontaneous Diabetes Produced by Selective Breeding of Normal Wistar Rats
GOTO, Y., KAKIZAKI, M., & MASAKI, N. (1975) · Proceedings of the Japan Academy · doi:10.2183/pjab1945.51.80 · Cited by 269
β-Cell Insensitivity to Glucose in the GK Rat, a Spontaneous Nonobese Model for Type II Diabetes
Portha, B., Serradas, P., Bailbé, D., Suzuki, K.-I., Goto, Y., & Giroix, M.-H. (1991) · Diabetes · doi:10.2337/diab.40.4.486 · Cited by 262
Research works printed but not linked: 3
- Odaka, 1994, Comparison of the effects of Voglibose (AO-128) and acarbose on postprandial hyperglycemia and intestinal carbohydrate absorption in rats, Jpn Pharmacol Ther, 22, 3491
- Lebovitz, 1998, α-Glucosidase inhibitors as agents in the treatment of diabetes, Diabetes Rev, 6, 132
- Takami, 1991, Antidiabetic actions of a disaccharidase inhibitor, AO-128, in spontaneously diabetic (GK) rats, Jpn Pharmacol Ther, 19, 4457
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681
Self-citationTourrel, C., Bailbe, D., Lacorne, M., Meile, M.-J., Kergoat, M., & Portha, B. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1443 · Cited by 285
Genistein, a soy isoflavone, is a potent α‐glucosidase inhibitor
Lee, D.-S., & Lee, S.-H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02631-x · Cited by 187
LEE, Y. A., CHO, E. J., TANAKA, T., & YOKOZAWA, T. (2007) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.53.287 · Cited by 186
Metadata
- Authors
- Koyama, M., Wada, R., Mizukami, H., Sakuraba, H., Odaka, H., Ikeda, H., & Yagihashi, S.
- Affiliations
- Hirosaki University (JP)
- Corresponding author
- Yagihashi, Soroku
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 49
- Issue
- 3
- Pages
- 347-352
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W1970437660
- Cited by
- 50
- References
- 33
- Citations by year
- 2024: 1 · 2022: 2 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 7
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- Goto-Kakizaki rats, type 2 diabetes, beta-cell mass, beta cell destruction, alpha-glucosidase inhibitors, voglibose, beta-cell proliferation, hyperglycemia, islet structure, beta-cell survival
- MeSH terms
- Aging, Animals, Body Weight, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Inositol, Islets of Langerhans, Male, Rats, Mutant Strains, Rats, Wistar, Rats, Glycoside Hydrolase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor. https://app.cochat.ai/papers/10.1016/s0026-0495(00)90242-7
- The paper
- Koyama, M., Wada, R., Mizukami, H., Sakuraba, H., Odaka, H., Ikeda, H., & Yagihashi, S. (2000). Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor. Metabolism. https://doi.org/10.1016/s0026-0495(00)90242-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.